Another study by Pei et al. showed a synergistic killing of MYC-dependent medulloblastoma cells when combining HDAC and PI3K inhibitors [145], an effect partly ascribed to the induction of the tumor suppressor FOXO1. The gene discussed is HDAC9; the disease is medulloblastoma.